Tru Niagen is now available at 700 retail
locations of The Vitamin Shoppe and Super Supplements™ and online
at vitaminshoppe.com
ChromaDex Corp. (NASDAQ:CDXC), the global authority on
nicotinamide adenine dinucleotide (NAD+) and healthy aging
research, announces that its flagship consumer supplement, Tru
Niagen®, is now available at The Vitamin Shoppe retail locations
nationwide and online at www.vitaminshoppe.com. This retail
expansion adds Tru Niagen to the shelves of 700 locations of The
Vitamin Shoppe and Super Supplements, enhancing consumer access to
the number one healthy-aging NAD+ supplement in the United
States†.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240425199897/en/
Tru Niagen, the number one healthy-aging
NAD+ supplement in the United States, launches at The Vitamin
Shoppe (Photo: Business Wire)
“This expands the distribution of Tru Niagen to an important
specialty retailer,” said Rob Fried, CEO of ChromaDex and Founder
of Tru Niagen. “The introduction of Tru Niagen into The Vitamin
Shoppe's network of stores underscores our commitment to making our
gold standard products accessible to a broader target
audience.”
Tru Niagen features NIAGEN® (patented nicotinamide riboside or
NR), the most efficient and superior NAD+ precursor that supports
cellular health, recovery, and vitality. Tru Niagen embodies the
highest scientific and quality standards and is backed by two Nobel
Prize winners, 30+ human clinical studies, 300+ published
scientific studies, and has been accepted by the world’s most
rigorous regulatory bodies.
Muriel Gonzalez, President of The Vitamin Shoppe, commented:
“From cellular health to cognitive function and mobility support,
innovative products that support longevity and healthspan are in
growing demand at The Vitamin Shoppe and Super Supplements. We’re
excited to introduce Tru Niagen’s advanced cellular health formulas
to our customers, who are seeking science-backed solutions to help
them achieve their lifelong wellness goals.”
Tru Niagen 300mg 30-count and 90-count bottles are now available
in the longevity aisle of The Vitamin Shoppe and Super Supplements
retail stores and at www.vitaminshoppe.com/truniagen.
For more information about the science behind Tru Niagen, please
visit www.truniagen.com.
About ChromaDex:
ChromaDex Corp. (NASDAQ:CDXC) is the global authority on
nicotinamide adenine dinucleotide (NAD+), with a focus on the
science of healthy aging. The ChromaDex team, comprised of
world-renowned scientists, works with independent investigators
from esteemed universities and research institutions around the
globe to uncover the full potential of NAD+. A vital coenzyme found
in every cell of the human body, NAD+ declines with age and
exposure to other everyday stressors. NAD+ depletion is a
contributor to age-related changes in health and vitality. Setting
the benchmark as the gold standard in scientific rigor, safety,
quality, and transparency, ChromaDex is the innovator behind its
clinically proven flagship ingredient, NIAGEN® (patented
nicotinamide riboside, or NR), the most efficient and
superior-quality NAD+ booster available.
NIAGEN NR is the active ingredient in ChromaDex’s consumer
products, sold as the brand Tru Niagen®, the number one
healthy-aging NAD+ supplement in the United States†. Clinically
proven to increase NAD+ levels, Tru Niagen is helping people around
the world transform the way they age (available at
www.truniagen.com). ChromaDex’s robust patent portfolio protects NR
and other NAD+ precursors. ChromaDex maintains a website at
www.chromadex.com, to which ChromaDex regularly publishes copies of
its press releases, news, and financial information.
†Based on the top-selling dietary supplement brands by revenue
per the largest U.S. e-commerce marketplace (as of
3/1/2023-2/29/2024).
About The Vitamin Shoppe®:
Lifelong Wellness Starts Here™. The Vitamin Shoppe®, a
subsidiary of Franchise Group, Inc., is a global, omnichannel
specialty retailer and wellness lifestyle Company with the mission
of providing customers with the most trusted products, guidance,
and services to support them on their journeys of lifelong
wellness. Based in Secaucus, New Jersey, the Company offers a
comprehensive assortment of nutritional solutions, including
vitamins, minerals, sports nutrition, specialty supplements, herbs,
homeopathic remedies, and green living products. In addition to
carrying products from approximately 700 national brands, The
Vitamin Shoppe offers products from its proprietary brands within
its owned and wholesale channels, including: The Vitamin Shoppe®,
Vthrive The Vitamin Shoppe®, BodyTech®, BodyTech® Elite,
fitfactor™, fitfactor KETO™, plnt®, ProBioCare®, True Athlete®, and
TrueYou™. In the U.S., the Company conducts business through
approximately 700 company-operated and franchise retail stores
under The Vitamin Shoppe and Super Supplements™ banners, and via
its website, www.vitaminshoppe.com. Globally, The Vitamin Shoppe
serves customers in select Asia, South America, and Central America
markets through local omnichannel partners.
Forward-Looking Statements:
This release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities and Exchange Act of 1934, as
amended, including statements related to the retail expansion
positioning Tru Niagen on the shelves of 700 The Vitamin Shoppe
locations and whether the partnership enhances consumer access to
Tru Niagen. Statements that are not a description of historical
facts constitute forward-looking statements and may often, but not
always, be identified by the use of such words as "expects,"
"anticipates," "intends," "estimates," "plans," "potential,"
"possible," "probable," "believes," "seeks," "may," "will,"
"should," "could" or the negative of such terms or other similar
expressions. Risks that contribute to the uncertain nature of these
forward-looking statements include the impact of the COVID-19
pandemic on our business and the global economy; our history of
operating losses and need to obtain additional financing; the
growth and profitability of our product sales; our ability to
maintain sales, marketing and distribution capabilities; changing
consumer perceptions of our products; our reliance on a single or
limited number of third-party suppliers; and the risks and
uncertainties associated with our business and financial condition.
More detailed information about ChromaDex and the risk factors that
may affect the realization of forward-looking statements is set
forth in ChromaDex's Annual Report on Form 10-K for the fiscal year
ended December 31, 2023, ChromaDex's Quarterly Reports on Form 10-Q
and other filings submitted by ChromaDex to the SEC, copies of
which may be obtained from the SEC's website at www.sec.gov.
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date hereof,
and actual results may differ materially from those suggested by
these forward-looking statements. All forward-looking statements
are qualified in their entirety by this cautionary statement and
ChromaDex undertakes no obligation to revise or update this release
to reflect events or circumstances after the date hereof.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240425199897/en/
ChromaDex Media Contact: Kendall Knysch, Senior Director
of Media Relations & Partnerships 310-388-6706 ext. 689
kendall.knysch@chromadex.com
ChromaDex Investor Relations Contact: Ben Shamsian Lytham
Partners 646-829-9701 shamsian@lythampartners.com
ChromaDex (NASDAQ:CDXC)
過去 株価チャート
から 12 2024 まで 1 2025
ChromaDex (NASDAQ:CDXC)
過去 株価チャート
から 1 2024 まで 1 2025
